Regulation of endothelial cell plasticity by TGF-β

Cell and Tissue Research

Volumn 347, Issue 1, 2012, Pages 177-186

  Van Meeteren, Laurens A ^a   Ten Dijke, Peter ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Angiogenesis; Cancer associated fibroblasts; EndMT; Endothelial cells; Epithelial to mesenchymal transition; Fibrodysplasia ossificans progressiva; Fibrosis; TGF

Indexed keywords

DISITERTIDE; FRESOLIMUMAB; LERDELIMUMAB; METELIMUMAB; TRANSFORMING GROWTH FACTOR BETA;

BINDING AFFINITY; BINDING SITE; CARCINOGENESIS; CELL DIFFERENTIATION; CELL FUNCTION; CELL TRANSFORMATION; DISEASE ACTIVITY; DRUG EFFECT; DRUG MECHANISM; ENDOTHELIUM CELL; FIBROBLAST; HEART MUSCLE FIBROSIS; HUMAN; LIVER FIBROSIS; MOLECULAR DYNAMICS; MOLECULAR INTERACTION; MOLECULAR PATHOLOGY; MYELOFIBROSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DETERMINATION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; REVIEW; SIGNAL TRANSDUCTION; SKIN FIBROSIS; SYSTEMIC SCLEROSIS; UNSPECIFIED SIDE EFFECT;

ANIMALS; BIOLOGICAL MARKERS; CELL DIFFERENTIATION; CELL TRANSDIFFERENTIATION; ENDOTHELIAL CELLS; FIBROSIS; HUMANS; MESODERM; NEOPLASMS; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA;

GASTROPODA;

EID: 84857824476     PISSN: 0302766X     EISSN: 14320878     Source Type: Journal    
DOI: 10.1007/s00441-011-1222-6     Document Type: Review

References (87)

1. Adams RH, Alitalo K (2007) Molecular regulation of angiogenesis and lymphangiogenesis. Nat Rev Mol Cell Biol 8:464-478 (Pubitemid 46823443)
2. Aisagbonhi O, Rai M, Ryzhov S, Atria N, Feoktistov I, Hatzopoulos AK (2011) Experimental myocardial infarction triggers canonical Wnt signaling and endothelial-to-mesenchymal transition. Dis Model Mech. doi:10.1242/dmm.006510
3. Allen M, Louise Jones J (2011) Jekyll and Hyde: the role of the microenvironment on the progression of cancer. J Pathol 223:163-177
4. Benton RL, Maddie MA, Dincman TA, Hagg T, Whittemore SR (2009) Transcriptional activation of endothelial cells by TGFßcoincides with acute microvascular plasticity following focal spinal cord ischaemia/reperfusion injury. ASN Neuro 1(3):181-194
5. Birukova AA, Adyshev D, Gorshkov B, Birukov KG, Verin AD (2005) ALK5 and Smad4 are involved in TGF-β1-induced pulmonary endothelial permeability. FEBS Lett 579:4031-4037 (Pubitemid 40961907)
6. Blobe GC, Schiemann WP, Lodish HF (2000) Role of transforming growth factor β in human disease. N Engl J Med 342:1350-1358 (Pubitemid 30408720)
7. Bujak M, Ren G, Kweon HJ, Dobaczewski M, Reddy A, Taffet G, Wang XF, Frangogiannis NG (2007) Essential role of Smad3 in infarct healing and in the pathogenesis of cardiac remodeling. Circulation 116:2127-2138 (Pubitemid 350060350)
8. Cano A, Perez-Moreno MA, Rodrigo I, Locascio A, Blanco MJ, del Barrio MG, Portillo F, Nieto MA (2000) The transcription factor snail controls epithelial-mesenchymal transitions by repressing Ecadherin expression. Nat Cell Biol 2:76-83
9. Cheifetz S, Hernandez H, Laiho M, ten Dijke P, Iwata KK, Massague J (1990) Distinct transforming growth factor-β (TGF-β) receptor subsets as determinants of cellular responsiveness to three TGF-βisoforms. J Biol Chem 265:20533-20538 (Pubitemid 120014040)
10. David L, Mallet C, Vailhe B, Lamouille S, Feige JJ, Bailly S (2007) Activin receptor-like kinase 1 inhibits human microvascular endothelial cell migration: potential roles for JNK and ERK. J Cell Physiol 213:484-489 (Pubitemid 47509730)
11. Denton CP, Merkel PA, Furst DE, Khanna D, Emery P, Hsu VM, Silliman N, Streisand J, Powell J, Akesson A, Coppock J, Hoogen F, Herrick A, Mayes MD, Veale D, Haas J, Ledbetter S, Korn JH, Black CM, Seibold JR (2007) Recombinant human anti-transforming growth factor β1 antibody therapy in systemic sclerosis: a multicenter, randomized, placebo-controlled phase I/II trial of CAT-192.Arthritis Rheum 56:323-333 (Pubitemid 46106206)
12. Dobaczewski M, Bujak M, Li N, Gonzalez-Quesada C, Mendoza LH, Wang XF, Frangogiannis NG (2010) Smad3 signaling critically regulates fibroblast phenotype and function in healing myocardial infarction. Circ Res 107:418-428
13. Egorova AD, Khedoe PP, Goumans MJ, Yoder BK, Nauli SM, ten Dijke P, Poelmann RE, Hierck BP (2011a) Lack of Primary Cilia Primes Shear-Induced Endothelial-to-Mesenchymal Transition. Circ Res 108(9):1093-1101
14. Egorova AD, Van der Heiden K, Van de Pas S, Vennemann P, Poelma C, DeRuiter MC, Goumans MJ, Gittenberger-de Groot AC, ten Dijke P, Poelmann RE, Hierck BP (2011b) Tgfß/Alk5 signaling is required for shear stress induced klf2 expression in embryonic endothelial cells. Dev Dyn 240(7):1670-1680
15. Eisenberg LM, Markwald RR (1995) Molecular regulation of atrioventricular valvuloseptal morphogenesis. Circ Res 77:1-6
16. Ezquerro IJ, Lasarte JJ, Dotor J, Castilla-Cortazar I, Bustos M, Penuelas I, Blanco G, Rodriguez C, Lechuga MC, Greenwel P, Rojkind M, Prieto J, Borras-Cuesta F (2003) A synthetic peptide from transforming growth factor β type III receptor inhibits liver fibrogenesis in rats with carbon tetrachloride liver injury. Cytokine 22:12-20 (Pubitemid 37222298)
17. Feng XH, Derynck R (2005) Specificity and versatility in tgf-βsignaling through Smads. Annu Rev Cell Dev Biol 21:659-693
18. Frid MG, Kale VA, Stenmark KR (2002) Mature Vascular Endothelium Can Give Rise to Smooth Muscle Cells via Endothelial- Mesenchymal Transdifferentiation: In Vitro Analysis. Circ Res 90:1189-1196 (Pubitemid 34786904)
19. Fujimoto M, Maezawa Y, Yokote K, Joh K, Kobayashi K, Kawamura H, Nishimura M, Roberts AB, Saito Y, Mori S (2003) Mice lacking Smad3 are protected against streptozotocin-induced diabetic glomerulopathy. Biochem Biophys Res Commun 305:1002-1007 (Pubitemid 36597863)
20. Ghosh AK, Vaughan DE (2011) PAI-1 in Tissue Fibrosis. J Cell Physiol. doi:10.1002/jcp.22783
21. Ghosh AK, Bradham WS, Gleaves LA, De TB, Murphy SB, Covington JW, Vaughan DE (2010) Genetic deficiency of plasminogen activator inhibitor-1 promotes cardiac fibrosis in aged mice: involvement of constitutive transforming growth factor-β signaling and endothelial-to-mesenchymal transition. Circulation 122:1200-1209
22. Gitler AD, Kong Y, Choi JK, Zhu Y, Pear WS, Epstein JA (2004) Tie2- Cre-induced inactivation of a conditional mutant Nf1 allele in mouse results in a myeloproliferative disorder that models juvenile myelomonocytic leukemia. Pediatr Res 55:581-584 (Pubitemid 38405843)
23. Goumans MJ, Mummery C (2000) Functional analysis of the TGFßreceptor/Smad pathway through gene ablation in mice. Int J Dev Biol 44:253-265
24. Goumans MJ, Valdimarsdottir G, Itoh S, Rosendahl A, Sideras P, ten Dijke P (2002) Balancing the activation state of the endothelium via two distinct TGF-β type I receptors. EMBO J 21:1743-1753 (Pubitemid 34614630)
25. Goumans MJ, Valdimarsdottir G, Itoh S, Lebrin F, Larsson J, Mummery C, Karlsson S, ten Dijke P (2003) Activin receptorlike kinase (ALK)1 is an antagonistic mediator of lateral TGFβ/ALK5 signaling. Mol Cell 12:817-828 (Pubitemid 37352776)
26. Goumans MJ, van Zonneveld AJ, ten Dijke P (2008) Transforming Growth Factor [β]-Induced Endothelial-to-Mesenchymal Transition: A Switch to Cardiac Fibrosis? Trends Cardiovasc Med 18:293-298
27. Hashimoto N, Phan SH, Imaizumi K, Matsuo M, Nakashima H, Kawabe T, Shimokata K, Hasegawa Y (2010) Endothelialmesenchymal transition in bleomycin-induced pulmonary fibrosis. Am J Respir Cell Mol Biol 43:161-172
28. Horwitz EM (2010) Building bone from blood vessels. Nat Med 16:1373-1374
29. Humphreys BD, Lin SL, Kobayashi A, Hudson TE, Nowlin BT, Bonventre JV, Valerius MT, McMahon AP, Duffield JS (2010) Fate tracing reveals the pericyte and not epithelial origin of myofibroblasts in kidney fibrosis. Am J Pathol 176:85-97
30. Ishisaki A, Hayashi H, Li AJ, Imamura T (2003) Human umbilical vein endothelium-derived cells retain potential to differentiate into smooth muscle-like cells. J Biol Chem 278:1303-1309 (Pubitemid 36790814)
31. Itoh S, ten Dijke P (2007) Negative regulation of TGF-β receptor/Smad signal transduction. Curr Opin Cell Biol 19:176-184 (Pubitemid 46386411)
32. Jakobsson L, Franco CA, Bentley K, Collins RT, Ponsioen B, Aspalter IM, Rosewell I, Busse M, Thurston G, Medvinsky A, Schulte-Merker S, Gerhardt H (2010) Endothelial cells dynamically compete for the tip cell position during angiogenic sprouting. Nat Cell Biol 12:943-953
33. Johnson NC, Dillard ME, Baluk P, McDonald DM, Harvey NL, Frase SL, Oliver G (2008) Lymphatic endothelial cell identity is reversible and its maintenance requires Prox1 activity. Genes Dev 22:3282-3291
34. Kalluri R, Zeisberg M (2006) Fibroblasts in cancer. Nat Rev Cancer 6:392-401
35. Kaplan FS, Shen Q, Lounev V, Seemann P, Groppe J, Katagiri T, Pignolo RJ, Shore EM (2008) Skeletal metamorphosis in fibrodysplasia ossificans progressiva (FOP). J Bone Miner Metab 26:521-530
36. Khan R, Sheppard R (2006) Fibrosis in heart disease: understanding the role of transforming growth factor-β in cardiomyopathy, valvular disease and arrhythmia. Immunology 118:10-24
37. Khaw P, Grehn F, Hollo G, Overton B, Wilson R, Vogel R, Smith Z (2007) A phase III study of subconjunctival human antitransforming growth factor β(2) monoclonal antibody (CAT-152) to prevent scarring after first-time trabeculectomy. Ophthalmology 114:1822-1830
38. Kizu A, Medici D, Kalluri R (2009) Endothelial-mesenchymal transition as a novel mechanism for generating myofibroblasts during diabetic nephropathy. Am J Pathol 175:1371-1373
39. Kokudo T, Suzuki Y, Yoshimatsu Y, Yamazaki T, Watabe T, Miyazono K (2008) Snail is required for TGFβ-induced endothelialmesenchymal transition of embryonic stem cell-derived endothelial cells. J Cell Sci 121:3317-3324
40. Krenning G, Zeisberg EM, Kalluri R (2010) The origin of fibroblasts and mechanism of cardiac fibrosis. J Cell Physiol 225:631-637
41. Lamouille S, Mallet C, Feige JJ, Bailly S (2002) Activin receptor-like kinase 1 is implicated in the maturation phase of angiogenesis. Blood 100:4495-4501 (Pubitemid 35429690)
42. Leong KG, Niessen K, Kulic I, Raouf A, Eaves C, Pollet I, Karsan A (2007) Jagged1-mediated Notch activation induces epithelial-tomesenchymal transition through Slug-induced repression of Ecadherin. J Exp Med 204:2935-2948 (Pubitemid 350179562)
43. Li Z, Jimenez SA (2011) Protein kinase C delta and the c-Abl kinase are required for transforming growth factor-β induction of endothelial- mesenchymal transition in vitro. Arthritis Rheum 63 (8):2473-2483
44. Li J, Qu X, Bertram JF (2009) Endothelial-myofibroblast transition contributes to the early development of diabetic renal interstitial fibrosis in streptozotocin-induced diabetic mice. Am J Pathol 175:1380-1388
45. Li J, Qu X, Yao J, Caruana G, Ricardo SD, Yamamoto Y, Yamamoto H, Bertram JF (2010) Blockade of Endothelial-Mesenchymal Transition by a Smad3 Inhibitor Delays the Early Development of Streptozotocin-Induced Diabetic Nephropathy. Diabetes 59:2612-2624
46. Liu Z, Kobayashi K, van Dinther M, van Heiningen SH, Valdimarsdottir G, van Laar T, Scharpfenecker M, Lowik CW, Goumans MJ, ten Dijke P, Pardali E (2009) VEGF and inhibitors of TGFßtype-I receptor kinase synergistically promote blood-vessel formation by inducing alpha5-integrin expression. J Cell Sci 122:3294-3302
47. Lopez D, Niu G, Huber P, Carter WB (2009) Tumor-induced upregulation of Twist, Snail, and Slug represses the activity of the human VE-cadherin promoter. Arch Biochem Biophys 482:77-82
48. Mallet C, Vittet D, Feige JJ, Bailly S (2006) TGFβ1 induces vasculogenesis and inhibits angiogenic sprouting in an embryonic stem cell differentiation model: respective contribution of ALK1 and ALK5. Stem Cells 24:2420-2427 (Pubitemid 44674302)
49. Markwald RR, Fitzharris TP, Smith WN (1975) Sturctural analysis of endocardial cytodifferentiation. Dev Biol 42:160-180
50. Massague J (1998) TGF-β signal transduction. Annu Rev Biochem 67:753-791
51. Mead AL, Wong TT, Cordeiro MF, Anderson IK, Khaw PT (2003) Evaluation of anti-TGF-β2 antibody as a new postoperative antiscarring agent in glaucoma surgery. Invest Ophthalmol Vis Sci 44:3394-3401 (Pubitemid 36909776)
52. Medici D, Shore EM, Lounev VY, Kaplan FS, Kalluri R, Olsen BR (2010) Conversion of vascular endothelial cells into multipotent stem-like cells. Nat Med 16:1400-1406
53. Medici D, Potenta S, Kalluri R (2011) Transforming Growth Factor-β2 promotes Snail-mediated endothelial-mesenchymal transition through convergence of Smad-dependent and Smad-independent signaling. Biochem J 437(3):515-520
54. Miyazono K (2009) Transforming growth factor-β signaling in epithelial-mesenchymal transition and progression of cancer. Proc Jpn Acad Ser B Phys Biol Sci 85:314-323
55. Moonen JR, Krenning G, Brinker MG, Koerts JA, van Luyn MJ, Harmsen MC (2010) Endothelial progenitor cells give rise to pro-angiogenic smooth muscle-like progeny. Cardiovasc Res 86:506-515
56. Moustakas A, Heldin CH (2005) Non-Smad TGF-β signals. J Cell Sci 118:3573-3584
57. Moustakas A, Heldin CH (2009) The regulation of TGFβ signal transduction. Development 136:3699-3714
58. Nataraj D, Ernst A, Kalluri R (2010) Idiopathic pulmonary fibrosis is associated with endothelial to mesenchymal transition. Am J Respir Cell Mol Biol 43:129-130
59. Nomura-Kitabayashi A, Anderson GA, Sleep G,Mena J, Karabegovic A, Karamath S, Letarte M, Puri MC (2009) Endoglin is dispensable for angiogenesis, but required for endocardial cushion formation in the midgestation mouse embryo. Dev Biol 335:66-77
60. Noseda M, McLean G, Niessen K, Chang L, Pollet I, Montpetit R, Shahidi R, Dorovini-Zis K, Li L, Beckstead B, Durand RE, Hoodless PA, Karsan A (2004) Notch Activation Results in Phenotypic and Functional Changes Consistent With Endothelialto- Mesenchymal Transformation. Circ Res 94:910-917 (Pubitemid 38490068)
61. Oh SP, Seki T, Goss KA, Imamura T, Yi Y, Donahoe PK, Li L, Miyazono K, ten Dijke P, Kim S, Li E (2000) Activin receptorlike kinase 1 modulates transforming growth factor-β 1 signaling in the regulation of angiogenesis. Proc Natl Acad Sci USA 97:2626-2631 (Pubitemid 30159221)
62. Oliver G, Srinivasan RS (2010) Endothelial cell plasticity: how to become and remain a lymphatic endothelial cell. Development 137:363-372
63. Potenta S, Zeisberg E, Kalluri R (2008) The role of endothelial- tomesenchymal transition in cancer progression. Br J Cancer 99:1375-1379
64. Quaggin SE, Kapus A (2011) Scar wars: mapping the fate of epithelial-mesenchymal-myofibroblast transition. Kidney Int 80(1):41-50
65. Sato M, Muragaki Y, Saika S, Roberts AB, Ooshima A (2003) Targeted disruption of TGF-β1/Smad3 signaling protects against renal tubulointerstitial fibrosis induced by unilateral ureteral obstruction. J Clin Invest 112:1486-1494 (Pubitemid 38056275)
66. Shore EM, Xu M, Feldman GJ, Fenstermacher DA, Cho TJ, Choi IH, Connor JM, Delai P, Glaser DL, LeMerrer M, Morhart R, Rogers JG, Smith R, Triffitt JT, Urtizberea JA, Zasloff M, Brown MA, Kaplan FS (2006) A recurrent mutation in the BMP type I receptor ACVR1 causes inherited and sporadic fibrodysplasia ossificans progressiva. Nat Genet 38:525-527
67. Siriwardena D, Khaw PT, King AJ, Donaldson ML, Overton BM, Migdal C, Cordeiro MF (2002) Human antitransforming growth factor β(2) monoclonal antibody-a new modulator of wound healing in trabeculectomy: a randomized placebo controlled clinical study. Ophthalmology 109:427-431 (Pubitemid 34184907)
68. Tang Y, Harrington A, Yang X, Friesel RE, Liaw L (2010) The contribution of the Tie2+ lineage to primitive and definitive hematopoietic cells. Genesis 48:563-567
69. Tarin D, Thompson EW, Newgreen DF (2005) The fallacy of epithelial mesenchymal transition in neoplasia. Cancer Res 65:5996-6000 (Pubitemid 40994379)
70. ten Dijke P, Arthur HM (2007) Extracellular control of TGFßsignalling in vascular development and disease. Nat Rev Mol Cell Biol 8:857-869
71. ten Dijke P, Goumans MJ, Pardali E (2008) Endoglin in angiogenesis and vascular diseases. Angiogenesis 11:79-89
72. Thiery JP, Sleeman JP (2006) Complex networks orchestrate epithelialmesenchymal transitions. Nat Rev Mol Cell Biol 7:131-142 (Pubitemid 43278296)
73. Thompson JE, Vaughan TJ, Williams AJ, Wilton J, Johnson KS, Bacon L, Green JA, Field R, Ruddock S, Martins M, Pope AR, Tempest PR, Jackson RH (1999) A fully human antibody neutralising biologically active human TGFβ2 for use in therapy. J Immunol Methods 227:17-29 (Pubitemid 29408701)
74. Timmerman LA, Grego-Bessa J, Raya A, Bertran E, Perez-Pomares JM, Diez J, Aranda S, Palomo S, McCormick F, Izpisua-Belmonte JC, de la Pompa JL (2004) Notch promotes epithelial-mesenchymal transition during cardiac development and oncogenic transformation. Genes Dev 18:99-115 (Pubitemid 38090691)
75. Van der Heiden K, Hierck BP, Krams R, de CR, Cheng C, Baiker M, Pourquie MJ, Alkemade FE, DeRuiter MC, Gittenberger-de Groot AC, Poelmann RE (2008) Endothelial primary cilia in areas of disturbed flow are at the base of atherosclerosis. Atherosclerosis 196:542-550
76. van Meeteren LA, Goumans MJ, ten Dijke P (2011) TGF-β Receptor Signaling Pathways in Angiogenesis; Emerging Targets for Anti- Angiogenesis Therapy. Curr Pharm Biotechnol (in press)
77. Wang A, Ziyadeh FN, Lee EY, Pyagay PE, Sung SH, Sheardown SA, Laping NJ, Chen S (2007) Interference with TGF-β signaling by Smad3-knockout in mice limits diabetic glomerulosclerosis without affecting albuminuria. Am J Physiol Renal Physiol 293:F1657-F1665 (Pubitemid 350086003)
78. Watabe T, Nishihara A, Mishima K, Yamashita J, Shimizu K, Miyazawa K, Nishikawa S, Miyazono K (2003) TGF-β receptor kinase inhibitor enhances growth and integrity of embryonic stem cell-derived endothelial cells. J Cell Biol 163:1303-1311 (Pubitemid 38032091)
79. Wong SH, Hamel L, Chevalier S, Philip A (2000) Endoglin expression on human microvascular endothelial cells - Association with betaglycan and formation of higher order complexes with TGF-βsignalling receptors. Eur J Biochem 267:5550-5560
80. Xu J, Lamouille S, Derynck R (2009) TGF-β-induced epithelial to mesenchymal transition. Cell Res 19:156-172
81. Yoshino T, Saito D, Tadokoro R, Takahashi Y (2011) In vivo gene manipulations of epithelial cell sheets: A novel model to study epithelial-to-mesenchymal transition. Dev Growth Differ 53:378-388
82. You LR, Lin FJ, Lee CT, DeMayo FJ, Tsai MJ, Tsai SY (2005) Suppression of Notch signalling by the COUP-TFII transcription factor regulates vein identity. Nature 435:98-104 (Pubitemid 40655915)
83. Zeisberg M, Duffield JS (2010) Resolved: EMT produces fibroblasts in the kidney. J Am Soc Nephrol 21:1247-1253
84. Zeisberg EM, Potenta S, Xie L, Zeisberg M, Kalluri R (2007a) Discovery of Endothelial to Mesenchymal Transition as a Source for Carcinoma-Associated Fibroblasts. Cancer Res 67:10123-10128 (Pubitemid 350070783)
85. Zeisberg EM, Tarnavski O, Zeisberg M, Dorfman AL, McMullen JR, Gustafsson E, Chandraker A, Yuan X, Pu WT, Roberts AB, Neilson EG, Sayegh MH, Izumo S, Kalluri R (2007b) Endothelial-to-mesenchymal transition contributes to cardiac fibrosis. Nat Med 13:952-961 (Pubitemid 47222040)
86. Zeisberg EM, Potenta SE, Sujimoto H, Zeisberg M, Kalluri R (2008) Fibroblasts in kidney fibrosis emerge via endothelial to mesenchymal transition. J Am Soc Nephrol 19(12):2282-2287
87. Zhang YE (2009) Non-Smad pathways in TGF-β signaling. Cell Res 19:128-139